ADMA Biologics, Inc. (ADMA)
16.43
+0.49
(+3.07%)
USD |
NASDAQ |
Feb 06, 16:00
16.42
-0.01
(-0.06%)
After-Hours: 20:00
ADMA Biologics SG&A Expense (TTM) : 96.37M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arcutis Biotherapeutics, Inc. | 253.18M |
| Marker Therapeutics, Inc. | 4.365M |
| CorMedix, Inc. | 75.56M |
| Editas Medicine, Inc. | 54.90M |
| Savara, Inc. | 37.38M |